Neurizon licenses animal health drug to Elanco for faster launch

Neurizon licenses animal health drug to Elanco for faster launch

The global licensing deal is set to accelerate the commercialization of a promising new therapy.
Elanco-Bayer acquisition pronounced legal

Elanco-Bayer acquisition pronounced legal

The VCCA found that the acquisition deal between Elanco Animal Health Inc. and Bayer AG does not violate Vietnam’s Competition Law.